Current Respiratory Infections in Germany: Colds, Flu, and COVID-19

Distinguishing between a common cold, influenza, and COVID-19 remains a significant challenge for millions of people, particularly as respiratory infections peak during winter months. With multiple seasonal viruses circulating simultaneously, overlapping symptoms often make self-diagnosis difficult without professional medical intervention.

In Germany, the Robert Koch Institute (RKI) monitors the activity of these acute respiratory infections through various data sources, including syndromic surveillance, wastewater monitoring for SARS-CoV-2, and genomic surveillance of virus variants.

Current Viral Landscape in Germany

Respiratory viruses circulating in the population typically include SARS-CoV-2, influenza, respiratory syncytial virus (RSV), and various cold viruses. The RKI provides regular updates and recommendations based on the current situation in Germany.

Health authorities have observed unusual patterns in how these viruses emerge. The European Centre for Disease Prevention and Control (ECDC) reported that in some periods, there was a significantly earlier increase in influenza cases than usual.

The ECDC warned that the influenza season could be more severe if vaccination rates remain low.

Comparing Symptoms and Onset

While coughing and sore throats are common across various respiratory infections, the onset and intensity of symptoms often differ depending on the specific virus.

A common cold, often referred to as a grippaler Infekt, is typically milder and develops gradually. These infections are frequently caused by adenoviruses, parainfluenza, or rhinoviruses.

In contrast, influenza, or the true flu, tends to strike suddenly and with greater intensity.

Because these infections all target the respiratory system, a definitive diagnosis cannot be achieved through symptom checklists alone; it requires certified tests and laboratory examinations.

Surveillance and Diagnostics

Integrated surveillance efforts are managed across Europe to track the epidemiological and virological situation. The European Respiratory Virus Surveillance Summary (ERVISS), which provided data as of March 27, 2026, offers a weekly integrated summary for influenza, RSV, and SARS-CoV-2 for the European Union/European Economic Area (EU/EEA) and the WHO European Region.

In Germany, specialized diagnostic centers manage the identification of these viruses:

• The RKI houses the German National Reference Centre for Influenza and the Consultant Laboratory for RSV, metapneumoviruses, and parainfluenza viruses.
• The National Reference Center for Coronaviruses is located at Charité in Berlin.
• The RKI has also been appointed as part of a consortium to serve as the EU reference laboratory for public health for respiratory viruses.

Broader Public Health Context

The complexity of managing these infections is highlighted by emerging research into treatments. Reports indicate the development of a multipurpose anti-viral pill that may potentially treat COVID-19, the flu, colds, and norovirus.

global trends are being monitored to determine if seasonal patterns are shifting. In Asia, surges in influenza have led to questions regarding whether getting sick year-round could become a new norm.

For the general public, the primary goal remains the accurate identification of the specific infection to determine appropriate care and necessary precautions to protect others.